Genmab Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	18,522	27,898	25,960	26,459	14,359	10,612
Market Cap Growth	-	7.47%	-1.89%	84.27%	35.31%	-
Enterprise Value	14,623	24,768	23,094	23,876	12,749	9,676
PE Ratio	30.35	35.51	57.94	33.92	44.42	47.01
PS Ratio	7.59	13.35	20.36	15.96	17.93	22.87
PB Ratio	4.11	7.10	7.72	8.44	6.85	8.63
P/FCF Ratio	18.56	53.86	86.71	26.35	79.18	128.85
P/OCF Ratio	17.61	49.49	76.90	25.09	72.55	68.17
EV/Sales Ratio	5.99	11.85	18.11	14.40	15.92	20.85
EV/EBITDA Ratio	-	-	-	-	29.80	38.87
EV/EBIT Ratio	14.56	22.54	32.99	19.52	29.80	38.87
EV/FCF Ratio	14.65	47.81	77.14	23.77	70.30	117.48
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.01	-
Debt / EBITDA Ratio	-	-	-	-	0.06	-
Debt / FCF Ratio	0.11	0.17	0.22	0.05	0.15	-
Quick Ratio	13.34	15.41	14.50	14.81	14.90	16.76
Current Ratio	13.34	15.48	14.50	15.00	14.88	16.74
Asset Turnover	0.50	0.51	0.36	0.51	0.47	0.40
Interest Coverage	4.99	11.21	6.58	4.79	409.43	147.55
Return on Equity (ROE)	14.70%	21.60%	14.10%	27.20%	20.20%	20.60%
Return on Assets (ROA)	13.10%	19.30%	12.70%	24.20%	18.80%	19.50%
Return on Capital (ROIC)	12.69%	17.65%	9.85%	26.17%	14.05%	15.72%
Earnings Yield	3.48%	2.82%	1.73%	2.95%	2.25%	2.13%
FCF Yield	5.39%	1.86%	1.15%	3.80%	1.26%	0.78%
Buyback Yield / Dilution	-0.36%	-0.32%	-0.84%	-1.20%	-	-
Total Shareholder Return	-0.36%	-0.32%	-0.84%	-1.20%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).